J Neurosci 2006, 26: 696707
The Medicines and Healthcare products Regulatory Agency (MHRA) has not approved retatrutide for any indication, and it does not feature in current NICE guidance or NHS treatment pathways
The needle should be inserted at a 90-degree angle for most patients, though very thin individuals may need to use a 45-degree angle or pinch the skin to ensure subcutaneous rather than intramuscular injection
JJH is supported by the Nordisk Foundation
Adding the glucagon receptor, which is what retatrutide does, introduces an entirely new metabolic lever that the body has not adapted to
demonstrate that the addition of a long-acting GIPR agonist (LY3537021) significantly reduced the total number of GI AEs induced with liraglutide treatment by 16% and numerically reduced nausea by 15% and vomiting by 3%, but not diarrhea (65)